DE69029732D1 - Bivalente metallsalze von indomethacin - Google Patents

Bivalente metallsalze von indomethacin

Info

Publication number
DE69029732D1
DE69029732D1 DE69029732T DE69029732T DE69029732D1 DE 69029732 D1 DE69029732 D1 DE 69029732D1 DE 69029732 T DE69029732 T DE 69029732T DE 69029732 T DE69029732 T DE 69029732T DE 69029732 D1 DE69029732 D1 DE 69029732D1
Authority
DE
Germany
Prior art keywords
indomethacin
salt
forming
solution
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029732T
Other languages
English (en)
Other versions
DE69029732T2 (de
Inventor
Hubertus Regtop
John Biffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biochemical Veterinary Research Pty Ltd
Original Assignee
Biochemical Veterinary Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemical Veterinary Research Pty Ltd filed Critical Biochemical Veterinary Research Pty Ltd
Publication of DE69029732D1 publication Critical patent/DE69029732D1/de
Application granted granted Critical
Publication of DE69029732T2 publication Critical patent/DE69029732T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Dental Preparations (AREA)
DE69029732T 1989-05-22 1990-05-21 Bivalente metallsalze von indomethacin Expired - Fee Related DE69029732T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ432889 1989-05-22
PCT/AU1990/000209 WO1990014337A1 (en) 1989-05-22 1990-05-21 Divalent metal salts of indomethacin

Publications (2)

Publication Number Publication Date
DE69029732D1 true DE69029732D1 (de) 1997-02-27
DE69029732T2 DE69029732T2 (de) 1997-05-07

Family

ID=3773930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029732T Expired - Fee Related DE69029732T2 (de) 1989-05-22 1990-05-21 Bivalente metallsalze von indomethacin

Country Status (12)

Country Link
US (1) US5310936A (de)
EP (1) EP0473655B1 (de)
KR (1) KR0156231B1 (de)
AT (1) ATE147731T1 (de)
CA (1) CA2058754C (de)
DE (1) DE69029732T2 (de)
DK (1) DK0473655T3 (de)
ES (1) ES2098264T3 (de)
IE (1) IE81142B1 (de)
NO (1) NO175148C (de)
NZ (1) NZ233776A (de)
WO (1) WO1990014337A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466824A (en) * 1989-05-22 1995-11-14 Biochemical Veterinary Research Pty. Ltd. Divalent metal complexes of indomethacin, compositions and medical methods of use thereof
FR2758819B1 (fr) * 1997-01-29 2000-01-21 Laprophan Laboratoires Pharma Indometacine calcique et sa preparation
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
EP1734945A4 (de) * 2004-03-30 2007-10-03 Medical Therapies Ltd Zusammensetzung mit einem komplex aus einem metallion und einem carboxylat-liganden mit entzündungshemmender wirkung
WO2007026240A1 (en) * 2005-09-01 2007-03-08 Medical Therapies Limited Sunscreen and cosmetic compositions for prophylaxis or treatment of skin cancers
HU227696B1 (en) * 2006-04-13 2011-12-28 Egyt Gyogyszervegyeszeti Gyar Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it
US11000533B2 (en) * 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9308196B2 (en) 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US8912226B2 (en) * 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6804994A (de) * 1967-04-11 1968-10-14
DK244179A (da) * 1978-06-13 1979-12-14 Merck & Co Inc Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
EP0405602A1 (de) * 1989-06-30 1991-01-02 Laboratorios Vinas S.A. Zinkderivate von antientzündlichen Arzneimitteln mit verbesserter therapeutischer Aktivität

Also Published As

Publication number Publication date
DK0473655T3 (da) 1997-02-10
NO914565D0 (no) 1991-11-21
KR920700639A (ko) 1992-08-10
EP0473655A1 (de) 1992-03-11
CA2058754A1 (en) 1990-11-23
EP0473655A4 (en) 1992-05-20
DE69029732T2 (de) 1997-05-07
IE81142B1 (en) 2000-04-19
NO175148B (no) 1994-05-30
ATE147731T1 (de) 1997-02-15
WO1990014337A1 (en) 1990-11-29
ES2098264T3 (es) 1997-05-01
CA2058754C (en) 2002-02-19
IE901831L (en) 1990-11-22
NZ233776A (en) 1991-09-25
NO175148C (no) 1994-09-07
US5310936A (en) 1994-05-10
NO914565L (no) 1992-01-21
EP0473655B1 (de) 1997-01-15
KR0156231B1 (ko) 1998-11-16

Similar Documents

Publication Publication Date Title
DE69029732D1 (de) Bivalente metallsalze von indomethacin
GEP20002032B (en) (54) Pyrido[2,3-d]Pyrimidines and Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Composition Comprising Them and Methods of Treatment
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
DK0660705T3 (da) Avanceret lægemiddelafgivelsessystem og fremgangsmåde til behandling af psykiatriske, neurologiske og andre lidelser med ca
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
ES8601965A1 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
DE69433013D1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
RU2008103617A (ru) Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза
Sillanpää Clonidine prophylaxis of childhood migraine and other vascular headache: a double blind study of 57 children
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
BE898749A (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DK47089D0 (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
ATE135909T1 (de) Verfahren zur behandlung von akne
ES535798A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
ITRM920693A1 (it) Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hivsieropositivi.
ATE244011T1 (de) Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
HUT48265A (en) Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components
Fishbain " Priapism and neuroleptics: A case report": Comment.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee